Company / FCF Margin
Gilead Sciences FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
32.1%
FY2025
5-year range
30.4% / 39.6%
FY2021-FY2025
Trend
-10.4%
vs FY2024
Sector context
#14 of 134
Health Care
What the data says
Among 134 Health Care companies, Gilead Sciences is in the top 10% for fcf margin. FCF Margin has fluctuated over the past 10 years, ranging from 30.4% in FY2022 to 62.8% in FY2017.
Based on SEC 10-K filings.
32.1% in FY2025 with a 5-year CAGR of +1.7%. Top quartile in the Health Care sector.
Declined from 39.6% to 32.1% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +1.7pp
- 5-Year Change
- +1.7pp
- 10-Year Change
- -
Sector benchmark
Top 10% in Health CareTop 10% of 134This company 32.1% Sector average -637.8%
▼
+105.0% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 10.4% year-over-year.
- Currently 669.9pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2017.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 32.1% | -10.4% |
| FY2024 | 35.8% | -9.4% |
| FY2023 | 39.6% | +30.0% |
| FY2022 | 30.4% | -17.8% |
| FY2021 | 37.1% | +21.7% |
| FY2020 | 30.4% | -29.7% |
| FY2019 | 43.3% | -19.2% |
| FY2018 | 53.6% | -14.6% |
| FY2017 | 62.8% | +27.5% |
| FY2016 | 49.3% | -21.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026